Podcast
Drug Pricing and Market Access: The RAPID Pathway
September 21, 2026
CMS proposed the RAPID pathway to fast-track Medicare coverage for breakthrough medical devices. The Latham team explores how the pathway works and what it means for device manufacturers.
The Centers for Medicare & Medicaid Services (CMS) proposed the Regulatory Alignment for Predictable and Immediate Device (RAPID) pathway to coordinate FDA device approval and Medicare coverage decisions under one coordinated process from the start — aiming to shrink a historically five-year gap to as few as 60-90 days.
In this episode of Connected With Latham, Washington, D.C. partners Chris Schott and Nate Beaton, along with associate Danny Machado, break down how RAPID works, how it differs from prior coverage initiatives, and what device manufacturers should consider as the pathway takes shape.
Listen here or subscribe via Apple Podcasts, Spotify, or anywhere else you listen to podcasts.